Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DBCO-PEG4-acetic-Val-Cit-PAB is a cleavable tetraethylene glycol-based linker for antibody-drug conjugate (ADC) synthesis, consisting of a dibenzocyclooctyne group, an acetic acid moiety, a valine-citrulline dipeptide, and a p-aminobenzyl alcohol end.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 260.00 |
Description | DBCO-PEG4-acetic-Val-Cit-PAB is a cleavable tetraethylene glycol-based linker for antibody-drug conjugate (ADC) synthesis, consisting of a dibenzocyclooctyne group, an acetic acid moiety, a valine-citrulline dipeptide, and a p-aminobenzyl alcohol end. |
In vitro | ADCs consist of an antibody conjugated to an ADC cytotoxin via an ADC linker [1]. |
Molecular Weight | 855.97 |
Formula | C45H57N7O10 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DBCO-PEG4-acetic-Val-Cit-PAB inhibitor inhibit